Secondary Parkinson disease

Secondary Parkinson disease refers to a group of disorders that present similarly to Parkinson disease but have different etiology. Secondary Parkinson disease is caused due to the blockade of or interference in dopamine’s action in the basal ganglia. Here is the latest research.

May 19, 2020
PreprintOpen Access

Endocannabinoids and dopamine balance basal ganglia output

bioRxiv
L. GorodetskiAlon Korngreen
April 24, 2020
Open Access

The microcircuits of striatum in silico

Proceedings of the National Academy of Sciences of the United States of America
J J Johannes HjorthSten Grillner
May 9, 2020

Dose-Dependent Effects of Lithium Treatment on the Aggravation of Antipsychotic-Induced Pisa Syndrome

Clinical Neuropharmacology
Huai-Te Hsieh, Yi-Wei Yeh
May 31, 2020

DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia

Movement Disorders : Official Journal of the Movement Disorder Society
Joanne NgManju A Kurian
April 3, 2020
Open Access

Habit learning in hierarchical cortex - basal ganglia loops

The European Journal of Neuroscience
Javier Baladron, Fred H Hamker
May 31, 2020

Dehydroepiandrosterone increases tonic and phasic dopamine release in the striatum

Neuroscience Letters
Iván Pérez-NeriCamilo Ríos
April 15, 2020

Current pharmacotherapy for tic disorders

Expert Opinion on Pharmacotherapy
Nicholas CothrosTamara Pringsheim
April 5, 2020
Review

Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia

CNS Drugs
Nicholas KeksGraham Meadows
March 28, 2020
Case Report

Restless legs syndrome following the use of ziprasidone: a case report

General Psychiatry
Cuizhen ZhuYezhe Lin
May 11, 2020

Beneficial effects of the phytocannabinoid Δ9 -THCV in L-DOPA-induced dyskinesia in Parkinson's disease

Neurobiology of Disease
Isabel EspadasRosario Moratalla
April 18, 2020
Review

The credit assignment problem in cortico-basal ganglia-thalamic networks: a review, a problem, and a possible solution

The European Journal of Neuroscience
Jonathan E RubinTimothy Verstynen
March 28, 2020
Open Access

The Role of the Subthalamic Nucleus in Inhibitory Control of Oculomotor Behavior in Parkinson's Disease

Scientific Reports
Shahab BakhtiariAbbas F Sadikot
April 17, 2020

Current Treatment Options and Emerging Agents for Schizophrenia

The Journal of Clinical Psychiatry
Christoph U Correll

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/secondary-parkinson-disease/58c23c89-e60a-438b-98d7-307241fb8d49